Posted on November 22, 202211/22/22
Ready or Not, Biosimilar Adalimumab Brings the Heat in 2023
Posted on October 17, 202210/17/22
Developing Best-in-class Copay Programs for Gross-to-Net
Posted on August 4, 20228/4/22
Macroeconomic Factors Impact Cash Flow for Pharma
Posted on April 7, 20224/7/22
Reigniting Revenue for Established Brands
Posted on April 7, 20224/7/22
Reignite Established Brands — Actual Use Case
Posted on April 29, 20214/29/21
Visualizing EVERSANA’s Omnichannel Activation Model
Posted on April 13, 20214/13/21
Expect More From Your Omnichannel Strategy and Investments
Posted on February 17, 20212/17/21
The Crush: How Covid-19 Is Impacting Mature Brand Revenue & Long-Term Value
Posted on January 19, 20211/19/21